Haemonetics (HAE) Financial Statements & Analysis

Haemonetics (HAE) Income Statement

Haemonetics reported revenue of $1.33B in fiscal 2026 (fiscal year ended Mar 31, 2026), down 2.0% from $1.36B a year earlier. Net income was $97.31M, down 42.0% year over year, a net margin of 7.3%. Gross margin was 55.7% and operating margin 18.1%. In the most recent quarter, Q1 fiscal 2027 (ended Jun 30, 2026), revenue was $339.38M, up 5.6% from the same quarter a year earlier.

Haemonetics Income Statement Analysis

Values in billions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Haemonetics Corporation income statement - Annual data in billions USD
Breakdown	FY 2026	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Mar 2026	Mar 2025	Mar 2024	Apr 2023	Mar 2023	Apr 2022	Mar 2022	Apr 2021	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017
Revenue & Gross Profit
Revenue	1.33	1.36	1.31	1.17	1.17	0.99	0.99	0.87	0.87	0.99	0.97	0.90	0.89
Cost of Revenue	0.59	0.61	0.62	0.55	0.55	0.46	0.46	0.47	0.44	0.50	0.55	0.49	0.51
Gross Profit	0.74	0.75	0.69	0.62	0.62	0.51	0.53	0.40	0.43	0.49	0.42	0.41	0.38
Operating Expenses
Research & Development	0.06	0.06	0.05	0.05	0.05	0.05	0.06	0.03	0.04	0.04	0.04	0.04	0.05
Selling, General & Administrative	0.44	0.44	0.43	0.37	0.38	0.33	0.33	0.28	0.26	0.27	0.30	0.32	0.30
Operating Expenses	0.50	0.55	0.52	0.46	0.46	0.42	0.45	0.31	0.34	0.38	0.33	0.36	0.40
Operating Income	0.24	0.20	0.18	0.16	0.16	0.08	0.08	0.09	0.09	0.10	0.08	0.06	-0.02
Other Income/Expense
Interest Income	0.00	0.00	0.00	-	0.00	-	0.00	-	0.00	0.00	0.00	0.00	0.00
Interest Expense	0.03	0.01	0.01	-0.01	0.01	-0.01	0.02	-0.01	0.02	0.02	0.01	0.00	0.01
Other Income/Expense	-0.11	0.02	-0.01	-0.01	0.00	-0.02	-0.02	-0.02	-0.02	-0.02	-0.01	0.00	-0.01
Income
Income Before Tax	0.13	0.21	0.15	0.14	0.14	0.06	0.06	0.07	0.07	0.09	0.07	0.06	-0.03
Income Tax Expense	0.03	0.04	0.03	0.03	0.03	0.02	0.02	-0.01	-0.01	0.01	0.02	0.01	0.00
Net Income	0.10	0.17	0.12	0.12	0.12	0.04	0.04	0.08	0.08	0.08	0.06	0.05	-0.03
Net Income - Continuous Operations	0.10	0.17	0.12	-	0.12	-	0.04	-	0.08	0.08	0.06	0.05	-0.03
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	0.31	0.34	0.26	0.25	0.25	0.19	0.19	0.17	0.18	0.26	0.19	0.15	0.12
EBIT	0.16	0.22	0.16	0.17	0.16	0.11	0.08	0.09	-	-	-	-	-
Depreciation & Amortization	0.16	0.05	0.03	0.08	0.03	0.09	0.09	0.08	0.08	0.09	0.11	0.09	0.08
Earnings Per Share
Basic EPS	2.00	3.00	2.00	2.00	2.00	1.00	1.00	2.00	2.00	2.00	1.00	1.00	-1.00
Diluted EPS	2.00	3.00	2.00	2.00	2.00	1.00	1.00	2.00	2.00	1.00	1.00	1.00	-1.00
Basic Shares Outstanding	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05
Diluted Shares Outstanding	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Haemonetics Financial Statements

What was Haemonetics's revenue in fiscal 2026?

Haemonetics reported revenue of $1.33B in fiscal 2026 (fiscal year ended Mar 31, 2026). That was down 2.0% from $1.36B a year earlier.

Is Haemonetics profitable?

Yes. Haemonetics earned net income of $97.31M in fiscal 2026, a net margin of 7.3%. In fiscal 2025 it earned $167.68M.

What is Haemonetics's operating margin?

Haemonetics's operating income was $241.40M on revenue of $1.33B in fiscal 2026, an operating margin of 18.1%, compared with 14.8% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition